Differential clinical characteristics of prescription of lithium vs. valproate: What do clinicians expect for lithium and valproate?

被引:0
|
作者
Owashi, T. [1 ]
Tanaka, H. [1 ]
Hida, M. [2 ]
Yokoyama, S. [2 ]
Kumata, T. [1 ,3 ]
Kudo, I. [1 ,2 ]
机构
[1] Showa Univ, Fujigaoka Hosp, Yokohama, Kanagawa 227, Japan
[2] Showa Univ, No Yokohama Hosp, Yokohama, Kanagawa, Japan
[3] Hiyoshi Hosp, Yokohama, Kanagawa, Japan
关键词
mood stabilizer; lithium; valproate; prescription; bipolar disorder;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:111 / 111
页数:1
相关论文
共 28 条
  • [1] Prescription of mood stabilizers : Lithium vs. valproate - what clinicians expect for them
    Owashi, T.
    Tanaka, H.
    Hida, M.
    Minegishi, G.
    Tamura, T.
    Yokoyama, S.
    Kudo, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 245 - 246
  • [2] Efficacy of lithium vs. valproate in the treatment of mania in the elderly: A retrospective study
    Chen, ST
    Altshuler, LL
    Melnyk, KA
    Erhart, SM
    Miller, E
    Mintz, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (03) : 181 - 186
  • [3] Lurasidone for Prevention of Recurrence in Patients With Bipolar I Disorder: Comparison of Adjunctive Therapy With Lithium Vs. Valproate
    Nemeroff, Charles
    Pikalov, Andrei
    Tsai, Joyce
    Mao, Yongcai
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S169 - S169
  • [4] Differential effects of chronic lithium and valproate on brain activation in healthy volunteers
    Bell, EC
    Willson, MC
    Wilman, AH
    Dave, S
    Silverstone, PH
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (06) : 415 - 424
  • [5] Effects of Mood Stabilizers on Psychomotor Functioning: Patients on Lithium or Valproate Monotherapy vs. Drug-Free Patients
    Atagun, Murat I.
    Balaban, Ozlem D.
    Yesilbas, Dilek
    Yesilyurt, Sema
    Keskinkilic, Cahit
    Evren, Cuneyt
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 137S - 137S
  • [6] Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records
    Hayes, Joseph F.
    Marston, Louise
    Walters, Kate
    Geddes, John R.
    King, Michael
    Osborn, David P. J.
    WORLD PSYCHIATRY, 2016, 15 (01) : 53 - 58
  • [7] Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden
    Bosi, Alessandro
    Clase, Catherine M.
    Ceriani, Laura
    Sjolander, Arvid
    Fu, Edouard L.
    Runesson, Bjoern
    Chang, Zheng
    Landen, Mikael
    Bellocco, Rino
    Elinder, Carl-Gustaf
    Carrero, Juan Jesus
    JAMA NETWORK OPEN, 2023, 6 (07) : E2322056
  • [8] Carbamazepine and valproate do not mimic the effects of lithium on inositol (I)phosphate accumulation in vivo
    Cook, SM
    Watt, AP
    Ragan, CI
    Atack, JR
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 102 - 102
  • [9] Bioequivalence of blood and salivary levels of lithium and valproate: Implications for the clinical management of bipolar disorder
    Murru, A.
    Callari, A.
    Varo, C.
    Torra, M.
    Gonzalez, B.
    Vieta, E.
    Colom, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S429 - S430
  • [10] Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
    Crapanzano, Calogero
    Casolaro, Ilaria
    Amendola, Chiara
    Damiani, Stefano
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (03) : 403 - 414